Narmada Agrobase Peer Comparison
NSE: NARMADA | BSE: 543643
₹13.96
As on 28-Aug-2026IST
Market cap
₹106 Cr
Revenue (TTM)
₹90 Cr
P/E Ratio
29.6
P/B Ratio
1.8
Div. Yield
0 %
| Narmada Agrobase | Godrej Agrovet | KSE | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
106 | 11,698 | 571 | 69 | 40 |
Revenue (₹ Cr) |
90 | 10,474 | 1,718 | 213 | 1 |
Net Profit (₹ Cr) |
3.59 | 384.15 | 46.43 | 4.66 | -0.40 |
Net Margin (%) |
3.96 | 3.63 | 2.68 | 2.18 | -40.89 |
RoE (%) |
6.13 | 24.56 | 13.15 | 5.10 | -- |
Price to Earnings |
29.58 | 26.18 | 12.29 | 14.85 | -- |
Price-To-Book |
1.77 | 5.47 | 1.63 | 0.73 | 1.76 |
Income Statement (₹ Cr)
| Narmada Agrobase | Godrej Agrovet | KSE | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Operating Revenue
|
78.39 | 10,232.68 | 1,680.48 | 182.38 | 0.63 |
|
Total Income
|
79.67 | 10,338.63 | 1,695.75 | 184.80 | 0.65 |
|
Total Expenditure
|
73.42 | 9,369.24 | 1,570.91 | 176.12 | 0.71 |
|
EBITDA
|
4.98 | 863.44 | 109.57 | 6.26 | -0.08 |
|
Depreciation
|
0.22 | 228.86 | 7.99 | 2.21 | 0.00 |
|
EBIT
|
4.75 | 634.58 | 101.59 | 4.05 | -0.08 |
|
Interest
|
0.82 | 138.27 | 2.78 | 0.73 | 0.00 |
|
Other Income
|
1.27 | 105.95 | 15.27 | 2.42 | 0.02 |
|
Exceptional Items
|
-- | -30.44 | 2.51 | -- | -- |
|
Profit before Tax
|
5.21 | 612.00 | 114.07 | 5.74 | -0.07 |
|
Provision for Tax
|
1.35 | 166.82 | 30.03 | 1.42 | -0.02 |
|
Profit after Tax
|
3.86 | 445.18 | 84.04 | 4.32 | -0.05 |
Liabilities (₹ Cr)
| Narmada Agrobase | Godrej Agrovet | KSE | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
59.34 | 2,032.08 | 349.50 | 91.19 | 15.09 |
|
Minority Interest
|
-- | 131.58 | -- | -- | -- |
|
Non-Current Liabilities
|
1.00 | 1,068.36 | 23.95 | 0.82 | -0.24 |
|
Current Liabilities
|
11.90 | 2,928.83 | 41.53 | 27.86 | 0.47 |
|
Total Liabilities
|
72.25 | 6,160.85 | 414.98 | 120.37 | 15.56 |
Assets (₹ Cr)
| Narmada Agrobase | Godrej Agrovet | KSE | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
11.69 | 3,388.41 | 65.26 | 45.04 | 0.03 |
|
Current Assets
|
60.54 | 2,758.50 | 349.72 | 74.48 | 15.30 |
|
Total Assets
|
72.25 | 6,160.85 | 414.98 | 120.37 | 15.56 |
|
Total Debt*
|
10.10 | 1,468.43 | 24.87 | 17.76 | 0.00 |
|
Net Current Assets
|
48.64 | -170.33 | 308.19 | 46.61 | 14.83 |
|
Contingent Liabilities
|
0.05 | 164.76 | 1.86 | -- | -- |
Cashflow (₹ Cr)
| Narmada Agrobase | Godrej Agrovet | KSE | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-1.30 | 1,281.17 | 53.52 | -5.73 | -0.02 |
|
Cash Flow from Investing Activities
|
-2.95 | -150.39 | -8.92 | -15.77 | -- |
|
Cash from Financing Activities
|
-0.18 | -868.90 | -33.22 | 15.09 | 0.00 |
|
Net Cash Inflow / Outflow
|
-4.43 | 261.88 | 11.38 | -6.41 | -0.02 |
Ratios
Profitability Ratios
| Narmada Agrobase | Godrej Agrovet | KSE | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
ROCE (%)
|
8.94 | 20.95 | 33.62 | 6.53 | -0.42 |
|
ROE (%)
|
6.70 | 20.25 | 26.01 | 4.84 | -0.32 |
|
ROA (%)
|
5.56 | 7.63 | 21.79 | 4.03 | -0.32 |
|
EBIT Margin (%)
|
7.97 | 9.47 | 7.43 | 4.76 | -9.48 |
|
Net Margin (%)
|
4.84 | 4.31 | 4.96 | 2.34 | -7.51 |
|
Cash Profit Margin (%)
|
5.21 | 6.28 | 5.48 | 3.58 | -7.04 |
Growth Ratios
| Narmada Agrobase | Godrej Agrovet | KSE | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
19.36 | 9.06 | 1.88 | 59.02 | -78.40 |
|
EBIT Growth (%)
|
0.18 | 12.76 | -2.69 | 50.67 | -283.97 |
|
Net Profit Growth (%)
|
-5.64 | 10.37 | -7.96 | 28.18 | -127.57 |
|
EPS Growth (%)
|
-5.64 | 9.99 | -7.96 | 28.14 | -127.48 |
|
Book Value Growth (%)
|
6.21 | -14.87 | 17.78 | 3.69 | -0.32 |
Valuation Ratios
| Narmada Agrobase | Godrej Agrovet | KSE | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Price / Earnings
|
29.99 | 21.74 | 6.71 | 15.30 | 0.00 |
|
Price / Book Value
|
1.95 | 5.08 | 1.61 | 0.73 | 0.47 |
|
Dividend Yield (%)
|
0.00 | 2.06 | 7.09 | 0.00 | 0.00 |
|
EV/EBITDA
|
18.47 | 11.80 | 4.40 | 9.62 | -117.54 |
|
Market Cap (₹ Cr)
|
115.67 | 10,276.68 | 564.14 | 66.15 | 7.11 |
Solvency Ratios
| Narmada Agrobase | Godrej Agrovet | KSE | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.17 | 0.73 | 0.07 | 0.20 | 0.00 |
|
Short term debt to equity ratio
|
0.15 | 0.19 | 0.00 | 0.18 | -- |
|
Current Ratio
|
5.09 | 0.94 | 8.42 | 2.67 | 32.43 |
|
Quick Ratio
|
3.90 | 0.48 | 4.97 | 1.26 | 18.08 |
|
Interest Coverage
|
7.36 | 5.43 | 41.96 | 8.87 | -37.71 |
Operating Efficiency Ratios
| Narmada Agrobase | Godrej Agrovet | KSE | Ajooni Biotech | Prism Medico | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
45.12 | 6.58 | 0.06 | 9.78 | 567.21 |
|
Asset Turnover
|
1.13 | 1.84 | 4.36 | 1.70 | 0.04 |
|
Receivable days
|
126.71 | 21.15 | 0.29 | 34.07 | 2,100.76 |
|
Inventory Days
|
87.41 | 44.46 | 27.72 | 63.48 | 3,910.85 |
|
Payable days
|
3.90 | 31.76 | 2.46 | 15.31 | -- |
|
Cash Conversion Cycle
|
210.22 | 33.86 | 25.54 | 82.25 | -- |